C-reactive protein as a predictor of cardiovascular risk in HIV-infected individuals
- 1 December 2014
- journal article
- research article
- Published by CSIRO Publishing in Sexual Health
- Vol. 11 (6) , 580-582
Abstract
Background: In some studies HIV infection confers approximately two-fold higher risk of cardiac events compared with the general population. C-reactive protein (CRP) is a well-characterised biomarker of cardiac events in the general population and is also elevated in patients with HIV infection. The aim of this study was to determine the predictive value of CRP for cardiac events in HIV-infected individuals. Methods: We retrospectively analysed CRP levels in stored plasma samples from HIV-infected patients who did or did not experience a coronary event in a case-controlled manner. All CRP measurements were performed using a high-sensitivity assay (hs-CRP). Results: Of the study participants with samples available, we found slightly elevated hs-CRP levels in the cardiac cases (median 3.5, IQR 1.6–14.4, n = 23) compared with controls (median 2.6, IQR1.2–8.3, n = 49) which were shown to not be statistically significant P = 0.20. Analysis of CRP as a binary variable (=5 mg L–1) was also not statistically significant (OR: 1.32, 95% CI 0.48–3.63). Conclusions: CRP levels may indicate elevated risk of future cardiac events, however this must be interpreted with caution due to the generalised elevation of CRP during HIV infection. CRP has no predictive value for atherosclerosis, and further research is required to improve early prediction of cardiovascular disease in HIV infection.Keywords
This publication has 14 references indexed in Scilit:
- High sensitivity C-reactive protein (Hs-CRP) remains highly stable in long-term archived human serumClinical Biochemistry, 2014
- Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV InfectionThe Journal of Infectious Diseases, 2010
- Association of HIV Infection and HIV/HCV Coinfection With C-Reactive Protein LevelsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- The role of C-reactive protein as a marker for cardiovascular risk associated with antiretroviral therapy in HIV-infected patientsAtherosclerosis, 2007
- Stability of Soluble Adhesion Molecules, Selectins, and C-Reactive Protein at Various Temperatures: Implications for Epidemiological and Large-Scale Clinical StudiesClinical Chemistry, 2007
- C-Reactive Protein Is a Marker for Human Immunodeficiency Virus Disease ProgressionArchives of internal medicine (1960), 2006
- Increased Cardiovascular Disease Risk Indices in HIV-Infected WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- C-Reactive Protein Is an Independent Predictor of Mortality in Women With HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patientsNutrition, 1999